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SUMMARY
Risk prediction procedures can be quite useful for the patient’s treatment selection, prevention
strategy or disease management in evidence-based medicine. Often potentially important new
predictors are available on top of the conventional markers. The question is how to quantify the
improvement from the new markers for prediction of the patient’s risk for cost-benefit decisions.
The standard method using the area under the receiver operating characteristic curve (AUROC)
to measure the added value may not be sensitive enough to capture incremental improvements
from the new markers. In this article, we address this issue for the case that the response variable
is the time, possibly censored, to a specific event of interest. We present graphical and numerical
methods for evaluating the predictive ability of the new markers. Our proposal includes most
of the recent procedures in the literature as special cases for alternatives to the AUROC-based
methods. The new inference procedures are theoretically justified and illustrated with data from
a cancer study to evaluate a new gene score for the prediction of patient’s survival.
Keywords: Area under the receiver operating characteristic curve; C-statistic; Cox’s regression;
Gaussian process; Integrated discrimination improvement; Improvement in the area under the
curve; Risk prediction.
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1. INTRODUCTION
Consider the case that the response variable T is the time to a specific event of interest, which
is possibly censored. Also let Z be its corresponding vector of baseline covariates or predictors.
Suppose that we are interested in predicting the risk p(Z) =pr(T ≤ t0 | Z), where t0 is a pre-
specified time point. Let Z(1) be a function of Z, which consists of the “conventional” predictor
values and Z(2) be a function of Z, which contains Z(1), but also new predictor values. The
question is whether a prediction model with Z(2) can improve the predictive ability over a model
with Z(1). The next question would be how to quantify the added value from the new markers
for cost-benefit decisions.
A commonly used statistical method to answer the first question is to fit the data with
a “working” survival model, for example, the Cox proportional hazards model, with Z(2) and
then utilize statistical significance tests for association of the new markers with the risk to
identify important new predictors. Unfortunately this approach sheds little light on the degree
of improvement from new markers. To answer the second question, a popular procedure is to
use the improvement in the area under the receiver operating characteristic curve (AUROC),
that is, compute the difference between two AUROC’s based on Z(1) and Z(2) (D’Agostino et al.,
1997; Bamber, 1975; Hanley & McNeil, 1982). Recently the time-specific AUROC methods have
been modified to deal with the censored event time data (Heagerty and Zheng, 2005; Cai and
Cheng, 2008; Uno et al, 2009). The resulting summary measures are called C-statistics (Harrell
et al., 1996; Pencina & D’Agostino, 2004). However, it has been shown that these metrics
are not sensitive enough to capture a meaningful improvement from the new markers over the
conventional counterparts (Pepe et al., 2004; Greenland & O’Malley, 2005; Ware, 2006). One
possible reason is that the difference of two AUROC’s does not leverage the pairing information
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of two risk scores within each study subject.
Recently, a number of new measures to quantify incremental values have been proposed (Cook
et al., 2006; Pencina et al., 2008). For the case in which there are no prespecified or well-defined
risk categories, Pencina et al. (2008) introduced the “integrated discrimination improvement”
(IDI) index and an “improvement in the AUROC” (IAUC) as new criteria for evaluating the
added value of new markers. Specifically, for a random independent subject, which is not in the
study sample, let Z = Z0, Z(1) = Z
0
(1) and Z(2) = Z
0
(2) denote its covariate vectors and let T = T
0
denote event time. With the censored event time data, let pˆ2(Z
0
(2)) and pˆ1(Z
0
(1)) be two estimates
for p(Z0), for example, via two survival working models. Define Dˆ(Z0) = pˆ2(Z
0
(2)) − pˆ1(Z0(1)).
Then, the IDI index is the limit of
E{Dˆ(Z0) | T 0 ≤ t0} −E{Dˆ(Z0) | T 0 > t0}, (1.1)
as the sample size goes to infinity. The IAUC is the limit of
pr(Dˆ(Z0) ≥ 0 | T 0 ≤ t0)− pr(Dˆ(Z0) ≥ 0 | T 0 > t0). (1.2)
Pepe et al. (2008) discussed the IDI extensively and connected it to other interesting dis-
crimination measures between cases and controls. Note that (1.1) is composed of two marginal
differences. The first one is the difference of two marginal means, pˆ2(·) and pˆ1(·), for those who
will develop the event. The second part of (1.1) is the difference of these two marginal means for
those subjects who will not have the event. The pairing information between pˆ2(·) and pˆ1(·) from
the same subject is not utilized to compute the IDI index. On the other hand, (1.2) does take
advantage of such pairing information. Under the usual random censorship model in survival
analysis, the large sample properties of the existing estimators for the IDI index and IAUC have
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not been studied in the literature for inferences. The standard bootstrapping method may not
work due to the fact that the estimation procedures are not smooth.
In this article, we generalize the above discrimination measures by considering two distribution
functions based on the paired difference Dˆ(·). The first one is
Fn(s) = pr(Dˆ(Z
0) ≤ s| T 0 ≤ t0}, (1.3)
and the second one is
Gn(u) = pr(Dˆ(Z
0) ≤ u| T 0 > t0}, (1.4)
where (s, u) ∈ [−1, 1] × [−1, 1] and the probabilities are with respect to the data and (T 0, Z0).
If we know (1.3) and (1.4), a plot of these two functions jointly can be quite informative as
shown in Figure 1 as an example. If there is no difference between two competing working
models, Fn(·) ≈ Gn(·), and thus we expect that Fn(·) − Gn(·) would be symmetric around 0.
The larger the separation between these two curves, the larger the improvement in performance
of the new markers with respect to the older ones. Any metric which quantifies the distance
between these two curves would be a reasonable measure of the added value. The IDI index is
simply the area between these two curves and the IAUC is the vertical distance between these
two functions evaluated at s = u = 0 (the distance between two gray dots in Figure 1). In this
paper, in the presence of censoring, we proposed consistent estimators for the limits of (1.3) and
(1.4). Furthermore, we show that as a process of (s, u), the joint distribution of the standardized
estimators for (1.3) and (1.4) is asymptotically Gaussian. We then show that this limiting
distribution can be approximated easily via a perturbation-resampling method, which is similar
to wild bootstrapping (Wu, 1986). With this approximation, one can then make inferences about
any “smooth” function of (1.3) and (1.4), for example, confidence interval estimates for the IDI
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and IAUC. We also derive inference procedures for other distance metrics between the above two
curves, for example, the difference of two medians from (1.3) and (1.4) (the horizontal distance
between two black dots in Figure 1). Lastly, we illustrate the new proposal with the data from
a breast cancer study to evaluate the degree of improvement from a new gene expression score
over the conventional clinical markers for predicting metastasis or mortality.
2. ESTIMATING THE DISTRIBUTION OF THE DIFFERENCE BETWEEN
TWO COMPETING RISK SCORES
Consider a general case that the event time T may not be observed completely. Let C be
the censoring variable, which is independent of T and Z. One can observe X = min(T, C) and a
binary indicator function ∆, which is one if T is observed. Let {(Ti, Ci, Zi)}, i = 1, · · · , n, be n in-
dependent copies of (T, C, Z). Let (Xi,∆i, Z(1i), Z(2i)) be the ith counterpart of (X,∆, Z(1), Z(2)),
in the sample. Also, let pˆk(Z(k)) be an estimator for p(Z) with the data {(Xi,∆i, Z(ki)), i =
1, · · · , n}, k = 1, 2.
To obtain estimates pˆk(Z(k)), k = 1, 2, one may use the conventional Cox regression models
(Cox, 1972). Specifically, at time point t, we model the cumulative hazard function Λ(t;Z(k)) of
T given Z(k) as Λk0(t) exp(β
′
kZ(k)), where Λk0(·) is the underlying cumulative hazard function,
and βk, is an unknown vector of parameters, for k = 1, 2. It is important to note that most likely
these models are not correctly specified. On the other hand, under a mild regularity condition,
the standard maximum partial likelihood estimator βˆk for βk converges to a constant vector, as
n→∞ (Hjort, 1992). This stability feature is essential for developing the large sample properties
of estimators for Fn and Gn. Using the standard Breslow estimator Λˆk0(t) for Λk0(t) (Kalbfleish
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& Prentice, 2002), one may estimate the risk p(Z0) by
pˆk(Z
0
(k)) = 1− exp{Λˆk0(t0) exp(βˆ ′kZ0(k))}, k = 1, 2, (2.7)
where Λˆk0(t) =
∑n
i=1
∫ t
0
{∑n
j=1 Yj(s)e
βˆ′
k
Z(kj)
}−1
dNi(s), Ni(t) = I(Xi ≤ t)∆i, I(·) is the indicator
function and Yi(t) = I(Xi ≥ t). The difference Dˆ(Z0) can then be defined accordingly. From
the large sample stability property of βˆk, it follows that Dˆ(·) converges to a finite deterministic
function D(·), as n→∞. Also, let the limits of Fn and Gn be denoted by F and G, respectively.
To estimate F and G in the presence of censoring, one may use the technique employed by
Chen et al. (1995). Specifically, let
Fˆ (s) =
∑n
i=1 ∆i{Hˆ(Xi)}−1I{Dˆ(Zi) ≤ s, Xi ≤ t0}∑n
i=1 ∆i{Hˆ(Xi)}−1I(Xi ≤ t0)
and
Gˆ(s) =
∑n
i=1 I{Dˆ(Zi) ≤ s, Xi > t0}∑n
i=1 I(Xi > t0)
,
where Hˆ(·) is the Kaplan-Meier estimator for the censoring distribution, H(t) = pr(C > t). The
proof of uniform consistency of the above estimators is given in the Appendix. Heuristically, the
expected value of n−1× numerator of Fˆ (·) is approximately equal to
E[∆1{H(X1)}−1I{D(Z1) ≤ s,X1 ≤ t0}]
= E[∆1{H(T1)}−1I{D(Z1) ≤ s, T1 ≤ t0 | T1, Z1}] ≈ pr{D(Z1) ≤ s, T1 ≤ t0}.
Similarly, the expected value of the standardized denominator of Fˆ is approximately equal to
pr(T1 ≤ t0).
To make further inferences about F (·) and G(·) or functions thereof, in the Appendix we
show that as n → ∞, the joint distribution of WF (s) =
√
n{Fˆ (s) − F (s)} and WG(u) =
6
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√
n{Gˆ(u)−G(u)} converges to a mean-zero Gaussian process indexed by (s, u) ∈ [−1, 1]×[−1, 1].
However, with the conventional method, the covariance functions of these limiting processes,
which involves the unknown density functions, cannot be estimated well. On the other hand,
a perturbation-resampling method, which is similar to a “wild” bootstrapping procedure, can
be utilized to generate independent realizations of a process which has the same distribution
of the above limiting Gaussian process. Specifically, let (x, δ, z), F˜ (·) and G˜(·) be the observed
value of (X,∆, Z), Fˆ (·) and Gˆ(·). Let {Vi, i = 1, . . . , n}, be a random sample from the standard
exponential distribution. let W ∗F (s) = n
1/2{F ∗(s) − F˜ (s)} and W ∗G(u) = n1/2{G∗(u) − G˜(u)}
where
F ∗(s) =
∑n
i=1 δi{H∗(xi)}−1I{D∗(zi) ≤ s, xi < t0}Vi∑n
i=1 δi{H∗(xi)}−1I(xi < t0)Vi
, (2.8)
G∗(u) =
∑n
i=1 I{D∗(zi) ≤ u, xi ≥ t0}Vi∑n
i=1 I(xi ≥ t0)Vi
, (2.9)
where H∗(·) and D∗(·) are perturbed counterparts of Hˆ(·) and Dˆ(·) by the same set of {Vi},
respectively. The details are given in the Appendix. It can be shown that when n is large, the joint
unconditional distribution of the process {WF (·),WG(·)} can be approximately well with that of
the process {W ∗F (·),W ∗G(·)}. In practice, the distribution of {WF (·),WG(·)} can be approximated
by a large number of realizations from {W ∗F (·),W ∗G(·)} via realized {Vi, i = 1, · · · , n}. It is
interesting to note that F ∗(·) and G∗(·) are non-decreasing functions.
Now, to make inferences about a “differentiable” function (van der Vaart, 1998, Chapter
20) H{F (·), G(·)} of {WF (·),WG(·)}, the distribution of n1/2[H{Fˆ (·), Gˆ(·)} − H{F (·), G(·)}]
can be approximated by the conditional (on the data) distribution of n1/2[H{F ∗(·), G∗(·)} −
H{F˜ (·), G˜(·)}]. Note that under the sup-norm metric or topology, one can use this approximation
to construct confidence intervals for the IDI and IAUC. Moreover, for making inference about
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the difference of two medians, we let H(F,G) = F−1(1/2)−G−1(1/2).
3. EXAMPLE
We illustrate the proposed method with the data from a breast cancer study to evaluate the
predictive value of a new biomarker, “wound-response gene expression signature”, for patient’s sur-
vival (Chang et al., 2005). For each patient, this gene score was derived from her microarray gene
expression data. The data set consists of 295 breast cancer patient files. Each file is composed of a
patient’s clinical outcomes (metastasis/death or censoring time), the gene score, and conventional
markers collected at time of surgery, including age, tumor diameter, number of positive lymph-
node, tumor grade, vascular invasion, estrogen receptor status, chemo/hormonal therapy or not,
and mastectomy or breast conserving surgery. The data are available at http://microarray-
pubs.stanford.edu/wound_NKI/explore.html. The gene expression data and the conventional
biomarker values were collected at the Netherlands Cancer Institute by van’t Veer et al. (2002)
and van de Vijver et al. (2002) to investigate the predictive ability of a gene score based on 70
specific gene expression data. The scoring system created by Chang et al. (2005) is different
from the so-called Dutch 70 scoring system. For this data set, the median follow-up duration
among the 295 patients was 6.7 years and the range was from 0.05 to 18.3 years (van de Vijver,
2002). Here, we are interested in quantifying the added value from the gene score by Chang et
al. over the above conventional predictors.
For illustration, we let T be the time to either the first metastasis or death. The Kaplan-Meier
curve based on the entire event times is given in Figure 1. The ten year event-free survival rate is
61.5%. Now, to evaluate the added value of the gene score over the conventional markers, we let
Z be the vector of all the aforementioned baseline covariate values. Furthermore, let Z(2) = Z,
8
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and Z(1) be the vector without the gene score. Let t0 = 10 (years). We fit the data with two
Cox proportional hazards models described in Section 2 with Z(1) and Z(2), respectively. The
regression coefficient estimates with the corresponding standard error estimates are reported
in Table 1. Although some regression parameters are not statistically significantly different
from 0, we include all the covariates in our analysis. For the ith patient with covariate vector
Zi in the sample, we then obtain a pair of risk scores {pˆ1(Z(1i)), pˆ2(Z(2i))} for approximating
p(Zi). In Figure 2, we present a scatter diagram whose x-axis and y-axis are pˆ1(·) and pˆ2(·),
respectively. The black dots represent the subjects who had events, the gray ones are those who
were event-free, and the open circles are for the censored observations before ten years. If there
are relatively few censored observations, visually this type of plot can be quite informative to
examine the added value of the gene score. If the gene score is “useless”, one would expect that
the black and gray dots are symmetrically distributed around the 45-degree line. For the present
case, the black dots tend to scatter above the 45-degree line and the gray ones are under the
diagonal line, indicating that the gene score indeed improves prediction. Moreover, this diagram
provides the “conventional” risk score value and the contrast between two scores within each
patient qualitatively and also quantitatively. Note that the observed standard C-statistics with
and without the gene score are 0.71 and 0.69, respectively. The improvement from the gene score
in C-statistic is only 0.02, and the corresponding 0.95 confidence interval is (-0.01, 0.05), which
covers null value zero.
Next we plot the estimated distribution functions Fˆ (·) and Gˆ(·) in Figure 3. Graphically the
gene score appears to provide extra information regarding the prediction of the ten year event
rates. The area between two curves is an estimated IDI index, which is 0.05 with a 0.95 confidence
interval of (0.02, 0.09). The vertical distance between two gray dots is an estimated IAUC, which
9
Hosted by The Berkeley Electronic Press
is 0.27 with a 0.95 confidence interval of (0.09, 0.45). The horizontal distance between two black
dots is an estimate of the median difference, which is 0.06 with a 0.95 confidence interval of (0.02,
0.10). Note that to obtain the standard error estimates, we utilized the perturbation-resampling
method discussed in Section 2 with 1000 realized independent samples of the unit exponential.
4. REMARKS
If there are very few censored observations before t0, the scatter diagram like Figure 3 is quite
informative to evaluate the added value of the new markers. For each subject, one can easily
see the incremental value of the risk score with the new markers as well as the corresponding
“conventional” score. For example, in Figure 3, for the subjects who had events, it appears that
the addition of the gene score does help when the conventional score is, say, more than 0.4.
Unfortunately, for the cancer example, the censoring proportion at year 10 is about 40%. Figure
3 by itself is not particularly useful. The distribution function plot in Figure 4 is informative for
the contrast of two scoring systems. However, it is not clear how to add the information of the
conventional score to such plots to explore where the gain would be from the new markers.
If we have pre-specified risk categories, for example, 0-10, 10-20, > 20 per cent ten-year risk,
one may use the net reclassification improvement (NRI) suggested by Cook et al. (2006) and
Pencina et al. (2008). With the perturbation-resampling method, it would be straightforward
to obtain an approximation to the distribution of the estimator of NRI. The confidence intervals
for such a metric can be obtained accordingly.
For the analysis of the data from the cancer study presented in Section 3, we discretized
the event time using ten-year cutoff time point to define “cases” and “controls”. Such a binary
outcome variable may not be able to capture differences between long and short term survivors.
10
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It would be interesting to generalize the inference procedures for the binary to ordinal categorical
outcomes or continuous responses.
5. APPENDIX
Let θk = (log {Λ0k(t0)} , β ′k)′ be a vector of parameters for k=1,2, and let pk(Z(k); θk) =
1− e− exp{(1,Z′(k))θk} and D(Z; θ1, θ2) = p2(Z(2); θ2)− p1(Z(1); θ1). Suppose that the estimator θˆk =(
log
{
Λˆ0k(t0)
}
, βˆ ′k
)′
converges to θk0, as n → ∞, and then pˆk(Z(k)) = pk(Z(k); θˆk) and Dˆ(Z) =
p2(Z(2); θˆ2) − p1(Z(1); θˆ1). Furthermore, we denote the parameter space for θk by Bk, k = 1, 2.
To derive the asymptotic properties, we assume that Bk is compact set containing θk0 and Z(k)
has bounded support. We also assume that D(Z; θ1, θ2) is a continuous random variable with a
density function continuous in θ1 ∈ B1 and θ2 ∈ B2.
Firstly, we will show the uniform consistency of Fˆ (s) and Gˆ(u). To this end, let
Fˆ (s, θ1, θ2) =
∑n
i=1 ∆iHˆ(Xi)
−1I{D(Zi; θ1, θ2) ≤ s, Xi ≤ t0}∑n
i=1 ∆iHˆ(Xi)
−1I(Xi ≤ t0)
.
It follows, from the uniform consistency of Hˆ(·) (Kalbfleish & Prentice, 2002) and a uniform law
of large numbers (Pollard, 1990), that
sup
(s,θ1,θ2)∈[−1,1]×B1×B2
∣∣∣Fˆ (s, θ1, θ2)− F (s, θ1, θ2)∣∣∣→ 0,
where
F (s, θ1, θ2) = pr{D(Z; θ1, θ2) ≤ s | T ≤ t0}.
Coupled with the convergence of θˆk → θk0, this implies that Fˆ (s, θˆ1, θˆ2) is uniformly consistent
for F (s, θ10, θ20) = F (s). The uniform consistency of Gˆ(·) is shown with the same argument.
Secondary, to derive the limiting distribution of WF (s) =
√
n
{
Fˆ (s)− F (s)
}
let
WFa(s, θ1, θ2) = n
1/2
{
Fˆ (s, θ1, θ2)− F (s, θ1, θ2)
}
11
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and
WFb(s) = n
1/2
{
F (s, θˆ1, θˆ2)− F (s)
}
.
Note that
WF (s) = WFa(s, θˆ1, θˆ2) +WFb(s), (5.1)
we will first show the stochastic equicontinuity of the process WFa(s, θ1, θ2) indexed by s, θ1 and
θ2. To this end, it is adequate to show that
n−1/2
n∑
i=1
[
∆i
Hˆ(Xi)
I{D(Zi; θ1, θ2) ≤ s,Xi ≤ t0} − pr{D(Zi; θ1, θ2) ≤ s, Ti ≤ t0}
]
(5.2)
is tight. From the standard asymptotic theory for the Kaplan-Meier estimator (Kalbfleish and
Prentice, 2002),
∆i
H(Xi)
= 1−
∫ τ
0
dMi(u)
H(u)
and 1− Hˆ(Xi)
H(Xi)
=
∫ Xi
0
dM(u)
πX(u)
+ op(n
−1/2),
where πX(t) = pr(Xi ≥ t), Mi(t) = I(Xi ≤ t,∆i = 0) −
∫ t
0
I(Xi ≥ u)dΛC(u), M(t) =∑n
i=1 Mi(t)/n, and ΛC(·) is the cumulative hazard function for the common censoring variable.
Using the aforementioned relationship (Bang & Tsiatis, 2000), (5.2) can be rewritten as
n−1/2
n∑
i=1
[I{D(Zi; θ1, θ2) ≤ s, Ti ≤ t0} − pr{D(Zi; θ1, θ2) ≤ s, Ti ≤ t0}]
− n−1/2
n∑
i=1
∫ τ
0
dMi(u)
H(u)
[I{D(Zi; θ1, θ2) ≤ s, Ti ≤ t0} −m(θ1, θ2, s, u)]
=n−1/2
n∑
i=1
[
I{D(Zi; θ1, θ2) ≤ s, Ti ≤ t0}
{
1−
∫ τ
0
dMi(u)
H(u)
}
− pr{D(Zi; θ1, θ2) ≤ s, Ti ≤ t0}
]
+ n−1/2
n∑
i=1
∫ τ
0
m(θ1, θ2, s, u)
dMi(u)
H(u)
, (5.3)
where
m(θ1, θ2, s, u) = pr{D(Z; θ1, θ2) ≤ s, T < t0 | T ≥ u}.
12
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To prove that (5.2) is tight in θ1, θ2 and s, one only needs to show that F = {D(z, θ1, θ2)− s :
θ1, θ2, s} is Donsker since the last term in (5.3) only involves a smooth deterministic function in
(θ1, θ2, s). Since Bk is bounded, it can be covered by Nk = O(ǫ
−dk) balls centered at θk[j] ∈ Bk
with a radius of ǫ, where j = 1, · · · , Nk and dk is the dimension of θk, k = 1, 2. Coupled with
the fact that Z has a bounded support, it implies that for any θk ∈ Bk, one can find 1 ≤
jk ≤ Nk such that |θ′k[jk]z˜k − θ′kz˜k| ≤ C1kǫ for a positive constant C1k, where z˜k = (1, z′k)′ and
zk ∈ support of Z(k). Furthermore, we can select N3 = O(ǫ−1) points in the interval [−1, 1] such
that −1 = s1 < s2 < · · · < sN3 = 1 and si − si−1 ≤ ǫ. Therefore for any θ1, θ2 and s, we can
find j1, j2 and j3, such that |{D(z; θ1, θ2) − s} − {e− exp(θ
′
1[j1]
z˜1) − e− exp(θ′2[j2]z˜2) − sj3}| ≤ C2ǫ. In
the following, we will estimate the bracketing number of F . Let
lijk(z) = I(e
− exp(θ′
1[i]
z˜1) − e− exp(θ′2[j]z˜2) − sk + C2ǫ ≤ 0)
and
uijk(z) = I(e
− exp(θ′
1[i]
z˜1) − e− exp(θ′2[j]z˜2) − sk − C2ǫ ≤ 0),
where 1 ≤ i ≤ N1, 1 ≤ j ≤ N2, 1 ≤ k ≤ N3. The brackets [lijk(z), uijk(z)], 1 ≤ i ≤ N1, 1 ≤ j ≤
N2, 1 ≤ k ≤ N3 covers F and
E[{uijk(Z)− lijk(Z)}2] = pr(|e− exp{(1,Z
′
(1)
)θ1[i]} − e− exp{(1,Z′(2))θ2[i]} − sk| < C2ǫ)
≤ sup
θ1,θ2,s
pr(|D(Z, θ1, θ2)− s| ≤ C2ǫ) ≤ C3ǫ,
since the density function ofD(Z, θ1, θ2) is uniformly bounded. Therefore, the bracketing number
of F is O(ǫ−2(d1+d2+1)) and thus F is Donsker. Thus, WFa(·, θ1, θ2) is tight and asymptotically,
WFa(·, θˆ1, θˆ2) is equivalent to WFa(·, θ10, θ20), uniformly in s.
Next by a Taylor series expansion,
WFb(s) = F˙θ1(s, θ10, θ20)n
1/2
(
θˆ1 − θ10
)
+ F˙θ2(s, θ10, θ20)n
1/2
(
θˆ2 − θ20
)
+ op(1) (5.4).
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where F˙θk =
∂F
∂θk
. Since regardless of model adequacy, the maximum partial likelihood estimator
θˆk is a regular estimator, i.e.,
n1/2
(
θˆk − θk0
)
= n−1/2
n∑
i=1
ψki + op(1)
where ψk1, · · · , ψkn are n i.i.d mean zero random variables. Coupled with (5.1), (5.3) and (5.4),
WF (s) = n
−1/2
n∑
i=1
πF (s, Zi, Xi,∆i) + op(1)
where
πF (s, Zi, Xi,∆i) =
F˙θ1(s, θ10, θ20)ψ1i + F˙θ2(s, θ10, θ20)ψ2i +
I{D(Zi; θ10, θ20) ≤ s, Ti ≤ t0}
{1− ST (t0)} − F (s)
−
∫ τ
0
dMi(u)
{1− ST (t0)}H(u) [I{D(Zi; θ10, θ20) ≤ s, Ti ≤ t0} −m(θ10, θ20, s, u)]
− F (s)
[
I(Ti ≤ t0)
1− ST (t0) − 1−
∫ τ
0
dMi(u)
{1− ST (t0)}H(u) {I(Ti ≤ t0)− pr(Ti ≤ t0|T ≥ u)}
]
,
where ST (t0) = pr(T > t0). Similarly, one may show that
WG(u) = n
−1/2
n∑
i=1
πG(u, Zi, Xi,∆i) + op(1)
uniformly in u. Therefore
 WF (s)
WG(u)

 = n−1/2
n∑
i=1

 πF (s;Zi, Xi,∆i)
πG(u;Zi, Xi,∆i)

+ op(1)
Following the similar arguments as above, one may show that the class of functions
{πF (s; z, x, δ), πG(u; z, x, δ)}′ indexed by s and u is Donsker and thus {WF (s),WG(u)}′ converges
to a mean zero two-dimensional Gaussian process on [−1, 1]× [−1, 1].
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The perturbed version of Hˆ in (2.7) is given by
H∗(t) = H˜(t)− H˜(t)
n∑
i=1
Vi
∫ t
0
{
n∑
j=1
I(xj > u)}−1dM˜i(u),
where H˜(·) is the observed Hˆ(·), M˜i(t) = I(xi ≤ t, δi = 0)−
∫ t
0
I(xi > u)dΛ˜C(u), and Λ˜C(·) is the
observed Nelson-Aalan estimator of the cumulative hazard function for the censoring variable C.
D∗(·) in (2.8) and (2.9) is given by
D∗(z) = p∗2(z(2))− p∗1(z(1))
= exp{Λ∗1(t0) exp(β∗′1 z(1))} − exp{Λ∗2(t0) exp(β∗′2 z(2))},
where β∗k and Λ
∗
k(t0) are given as Cai et al. (2009), i.e., β
∗
k − β˜k and log{Λ∗k0(t)} − log
{
Λ˜k0(t)
}
are
A˜k
−1
n∑
i=1
δi
[
(Vi − 1)
{
z(ki) − S˜
(1)
k (xi, β˜k)
S˜
(0)
k (xi, β˜k)
}
−
n−1
∑n
j=1(Vj − 1)I(xj ≥ xi)eβˆ
′
k
z(kj)
{
S˜
(0)
k (xi, β˜k)z(kj) − S˜(1)k (xi, βˆk)
}
S˜
(0)
k (xi, β˜k)
2

 ,
and
n−1
Λ˜k0(t)
n∑
i=1
I(xi ≤ t)δi
{
(Vi − 1)
S˜
(0)
k (xi, β˜k)
−n
−1
∑n
j=1(Vj − 1)I(xj ≥ xi)eβ˜
′
k
z(kj) + S˜
(1)
k (xi, β˜K)
′(β∗k − β˜k)
S˜
(0)
k (xi, β˜k)
2
}
,
respectively, where β˜k is the observed βˆk, Λ˜k0(t) is the observed Λˆk0(t), S˜
(m)
k (t, βk) = n
−1
∑n
i=1 I(xi ≥
t)eβkz(ki)z⊗m(ki) ,
A˜k =
∫  S˜(2)k (t, β˜k)
S˜
(0)
k (t, β˜k)
−
{
S˜
(1)
k (t, β˜k)
S˜
(0)
k (t, β˜k)
}⊗2 S˜(0)k (t, β˜k)dΛ˜k0(t)
and for any vector x, x⊗0 = 1, x⊗1 = x, x⊗2 = x′x.
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Now, let θ∗k = (log {Λ∗0k(t0)} , β∗′k ) and θ˜k0 be the observed θˆk0, it can be shown that n1/2
(
θ∗k − θ˜k
)
conditional on data and n1/2
(
θˆk − θk0
)
converges to the same limiting normal distribution (Cai
et al., 2009). Furthermore, using similar expressions given as (5.1), (5.3), and (5.4), it is also
straightforward to show that {W ∗F (s),W ∗G(u)}′ can be approximated by
n−1/2
∑n
i=1{π˜F (s; zi, xi, δi), π˜G(u; zi, xi, δi)}′(Vi− 1), where π˜F (s; z, x, δ) and π˜G(u; z, x, δ) are ob-
served counterparts of πF (s; z, d, δ) and πG(u; z, d, δ), respectively. Therefore, by functional delta
method, the distribution of WH = n
1/2[H{Fˆ (·), Gˆ(·)} − H{F (·), G(·)}] can be approximated by
that ofW ∗H = n
1/2[H{F ∗(·), G∗(·)}−H{F˜ (·), G˜(·)}] conditional on the observed data in the sense
that pr{|W ∗H −WH | ≥ ǫ|(Zi, Xi,∆i), i = 1, · · · , n} converges to 0 in probability for any ǫ > 0.
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Table 1. Estimates of regression parameters for Cox’s models with breast cancer data
Model without gene score Model with gene score
Est.(1) SE(2) p(3) Est. SE p
Age/10 [yrs] -0.47 0.17 0.01 -0.57 0.18 0.00
Diameter of tumor [cm] 0.19 0.11 0.10 0.18 0.12 0.12
Lymph nodes 0.00 0.08 0.98 -0.01 0.08 0.90
Grade = 2 vs 1 1.00 0.35 0.00 0.74 0.35 0.04
Grade = 3 vs 1 1.11 0.35 0.00 0.66 0.37 0.08
Vascular invasion 1-3 vs 0 0.08 0.37 0.83 -0.10 0.37 0.78
Vascular invasion >3 vs 0 0.81 0.62 0.19 0.64 0.63 0.30
Estrogen Status=Positive -0.39 0.23 0.09 -0.16 0.24 0.51
Chemo or Hormonal =Yes -0.54 0.33 0.11 -0.49 0.33 0.14
Mastectomy=Yes 0.13 0.21 0.54 0.21 0.22 0.34
Gene score - - - 2.43 0.67 0.00
(1) Estimate
(2) Standard error estimate
(3) p-value
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Figure 1. A hypothetical example for distribution functions of Dˆ for subjects with events and
for those without
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Figure 2. Kaplan-Meier estimate for metastasis/death with breast cancer data
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Figure 3. Scatter diagram of pˆ1 vs. pˆ2 for “with event” and “without event” with breast cancer
data
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Figure 4. Empirical distribution function with Dˆ(s) for “with event” and “without event” with
breast cancer data
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